Literature DB >> 4365934

Metabolism and action of the hormone vitamin D. Its relation to diseases of calcium homeostasis.

J W Coburn, D L Hartenbower, A W Norman.   

Abstract

Extensive experimental evidence has established a significant role of calciferol in the maintenance of normal calcium homeostasis. Present knowledge indicates that vitamin D(3) must first be converted to 25-OH-D(3) and then to 1,25(OH)(2)D(3), the most active known form of the steroid. Many of the factors regulating the rate of production of this last steroid from its precurser have been evaluated, and the concept that vitamin D functions as a steroid hormone seems to be well established. Deranged action of calciferol, caused by impaired metabolism of the steroid or through altered sensitivity of target tissues, may be involved in the pathophysiology of several disease states with abnormal calcium metabolism. It is noted that liver disease, osteomalacia due to anticonvulsant therapy, chronic renal failure, hypophosphatemic rickets, hypoparathyroidism, hyperparathyroidism, sarcoidosis and idiopathic hypercalciuria have possible relation to alterations in metabolism or action of vitamin D. The future clinical availability of 1,25(OH)(2)D(3) and other analogs of this steroid may offer potential therapeutic benefit in the treatment of certain of the disease entities discussed.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4365934      PMCID: PMC1129480     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


  165 in total

1.  Refractoriness to antitetanic therapy in a case of surgical hypoparathyroidism.

Authors:  R W BLOHM; O A WURL; J O GILLESPIE; R F ESCAMILLA
Journal:  J Clin Endocrinol Metab       Date:  1953-05       Impact factor: 5.958

2.  The measurement and the meaning of urinary calcium.

Authors:  B E Nordin; A Hodgkinson; M Peacock
Journal:  Clin Orthop Relat Res       Date:  1967 May-Jun       Impact factor: 4.176

3.  Action of 1,25-dihydroxycholecalciferol, a potent, kidney-produced metabolite of vitamin D, in uremic man.

Authors:  A S Brickman; J W Coburn; A W Norman
Journal:  N Engl J Med       Date:  1972-11-02       Impact factor: 91.245

4.  Metabolism of 1,2 H 3 -4-C 14 -cholecalciferol in normal, uremic and anephric subjects.

Authors:  K Schaefer; D von Herrath; R Stratz
Journal:  Isr J Med Sci       Date:  1972-01

5.  25,26-dihydroxycholecalciferol, a metabolite of vitamin D3 with intestinal calcium transport activity.

Authors:  H F DeLuca; T Suda; H K Schnoes; Y Tanaka; M F Holick
Journal:  Biochemistry       Date:  1970-11-24       Impact factor: 3.162

6.  Vitamin-D deficiency and primary hyperparathyroidism.

Authors:  N J Woodhouse; F H Doyle; G F Joplin
Journal:  Lancet       Date:  1971-08-07       Impact factor: 79.321

7.  Basic studies on the mechanism of action of vitamin D.

Authors:  A W Norman; M R Haussler; T H Adams; J F Myrtle; P Roberts; K A Hibberd
Journal:  Am J Clin Nutr       Date:  1969-04       Impact factor: 7.045

8.  Absorption of vitamin D3-3H in control subjects and patients with intestinal malabsorption.

Authors:  G R Thompson; B Lewis; C C Booth
Journal:  J Clin Invest       Date:  1966-01       Impact factor: 14.808

9.  Biologically active metabolite of vitamin D3 from bone, liver, and blood serum.

Authors:  J Lund; H F DeLuca
Journal:  J Lipid Res       Date:  1966-11       Impact factor: 5.922

10.  1,25 Dihydroxy-vitamin D3 in normal man and patients with renal failure.

Authors:  A S Brickman; J W Coburn; S G Massry; A W Norman
Journal:  Ann Intern Med       Date:  1974-02       Impact factor: 25.391

View more
  3 in total

1.  Clinical use of 1-alpha-hydroxyvitamin D3.

Authors: 
Journal:  Br Med J       Date:  1978-06-17

2.  Time Course of Vitamin D Depletion and Repletion in Reproductive-age Female C57BL/6 Mice.

Authors:  Anthony M Belenchia; Sarah A Johnson; Alyssa C Kieschnick; Cheryl S Rosenfeld; Catherine A Peterson
Journal:  Comp Med       Date:  2017-12-01       Impact factor: 0.982

3.  Is the serum vitamin D level at the time of hospital-acquired acute kidney injury diagnosis associated with prognosis?

Authors:  Lingyun Lai; Jing Qian; Yanjiao Yang; Qionghong Xie; Huaizhou You; Ying Zhou; Shuai Ma; Chuanming Hao; Yong Gu; Feng Ding
Journal:  PLoS One       Date:  2013-05-22       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.